Tofacitinib in Combinazione con Metotrexato in Pazienti con Artrite Reumatoide: Efficacia Clinica, Risultati Radiografici e di Sicurezza dallo Studio di Fase 3 di 24 Mesi ORAL Scan
Arthritis Rheumatol. 2019 Jun;71(6):878-891
RA patients receiving TOF 5 or 10 mg BID plus MTX showed sustained clinical and radiographic treatment effects through months 12-24. The safety profile was consistent with previous TOF studies. The 12-month data from the ORAL Scan study have been previously reported. This report assesses durability of responses, including structural damage progression, and safety with TOF through 24 months. Patients were randomized 4:4:1:1 to receive TOF 5 or 10 mg BID, or PBO advanced to TOF with stable, backgr...